Polypid Ltd

General ticker "PYPD" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $19.4M

Polypid Ltd does not follow the US Stock Market performance with the rate: -43.0%.

Estimated limits based on current volatility of 7.8%: low 3.12$, high 3.65$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.67$, 8.95$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.41$, 7.28$]

Financial Metrics affecting the PYPD estimates:

  • Negative: Non-GAAP EPS, $ of -19.68 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -73.84 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31

Similar symbols

Short-term PYPD quotes

Long-term PYPD plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $42.88MM $38.89MM $22.87MM
Operating Income $-42.88MM $-38.89MM $-22.87MM
Non-Operating Income $0.54MM $-0.54MM $-0.93MM
Interest Expense $0.00MM $1.02MM $1.71MM
R&D Expense $30.42MM $27.99MM $16.15MM
Income(Loss) $-42.33MM $-39.43MM $-23.80MM
Taxes $-1.62MM $0.10MM $0.07MM
Profit(Loss) $-40.71MM $-39.52MM $-23.86MM
Stockholders Equity $36.23MM $5.86MM $-2.10MM
Inventory $22.50MM $0.21MM $0.00MM
Assets $44.23MM $25.97MM $15.37MM
Operating Cash Flow $-32.39MM $-34.32MM $-17.24MM
Capital expenditure $2.99MM $1.77MM $0.20MM
Investing Cash Flow $36.90MM $16.57MM $3.80MM
Financing Cash Flow $1.03MM $16.43MM $9.98MM
Earnings Per Share* $-65.24 $-61.04 $-16.99

* EPS are Split Adjusted, recent splits may be reflected with a delay.